Besides, we did not report differences in JRE of TAS1R3 (Figure 3A), TAS2R14 (Figure 3C) or TAS2R38 (Figure 3E) between NL group and NAFLD subjects. This evidence concerns the gene TAS2R38 and metabolic dysfunction-associated steatotic liver disease.